The aim of the present study was to investigate the prognostic and predictive value of p53 expression in tumour samples from a large group of ovarian cancer patient with clinical data collected through centres in the United Kingdom and the Netherlands, and to test the hypothesis that p53 status could be a reproducible marker for clinical outcome following therapy in ovarian cancer. Here, TP53 is linked to ovarian carcinoma.